文献速递消化道肿瘤与早癌消化内镜

德国与美国结肠镜检查使用对结直肠癌死亡率公共卫生影响的研究

Public health impact of colonoscopy use on colorectal cancer mortality in Germany and the United States.
PubMed 文献 · Gastrointest Endosc · 2017-04-19

该研究基于人群分析,评估2008至2011年德国与美国55至79岁成年人结肠镜检查使用对结直肠癌死亡的公共卫生影响。德国36.6%的结直肠癌死亡归因于未使用结肠镜,美国2008至2009年为38.2%、2010至2011年为33.6%;理论预防比例德国30.7%,美国分别为29.0%和33.9%。结论认为近期结肠镜使用可能预防了相当比例的结直肠癌死亡,增加目标人群结肠镜使用可避免更多死亡。

要点

  • 德国36.6%的结直肠癌死亡归因于未使用结肠镜(95%可信区间27.3%-45.5%)。
  • 美国2008至2009年归因比例38.2%,2010至2011年33.6%。
  • 理论预防比例德国30.7%,美国两时段分别为29.0%和33.9%。

核心结论

  • 近期结肠镜使用可能预防了德国和美国相当比例的结直肠癌死亡,增加目标人群结肠镜使用可避免更多死亡。
  • 归因分数和预防分数可为结肠镜使用的公共卫生影响提供有价值信息并指导政策制定。

研究设计与样本

  • 基于人群的分析,评估2008至2011年德国与美国55至79岁成年人结肠镜检查使用对结直肠癌死亡的影响。
  • 使用全国代表性健康调查的结肠镜使用数据、医学文献的相对风险估计和结直肠癌死亡登记数据计算归因分数、预防分数及影响数。

主要发现

  • 德国36.6%(95%可信区间27.3%-45.5%)的结直肠癌死亡归因于未使用结肠镜。
  • 美国2008至2009年归因比例为38.2%(95%可信区间28.6%-47.1%),2010至2011年为33.6%(95%可信区间24.8%-42.2%)。
  • 10年内结肠镜使用理论预防的结直肠癌死亡比例德国为30.7%(95%可信区间24.8%-35.7%)。
  • 美国理论预防比例2008至2009年为29.0%(95%可信区间23.4%-33.6%),2010至2011年为33.9%(95%可信区间27.4%-39.2%)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Colonoscopy has been demonstrated to be effective in reducing colorectal cancer (CRC) incidence and mortality and has been widely used for primary CRC screening in Germany and the United States. We performed a population-based analysis to evaluate and compare the public health impact of recent colonoscopy use on CRC deaths among adults aged 55 to 79 years in Germany and the United States from 2008 to 2011. METHODS: The epidemiologic metrics of attributable fraction and prevented fraction as well as the impact numbers were calculated using colonoscopy utilization data from nationally representative health surveys, relative risk estimates from medical literature, and CRC death registry data. RESULTS: Overall, 36.6% (95% credible interval [CrI], 27.3%-45.5%) of CRC deaths in Germany were estimated to be attributable to nonuse of colonoscopy, compared with the U.S. estimates of 38.2% (95% CrI, 28.6%-47.1%) and 33.6% (95% CrI, 24.8%-42.2%) for years 2008 to 2009 and 2010 to 2011, respectively. The proportion of CRC deaths theoretically prevented by colonoscopy use within 10 years was 30.7% (95% CrI, 24.8%-35.7%) in Germany, whereas in the United States this proportion ranged from 29.0% (95% CrI, 23.4%-33.6%) for 2008 to 2009 to 33.9% (95% CrI, 27.4%-39.2%) for 2010 to 2011. CONCLUSIONS: Recent colonoscopy use is likely to have prevented a considerable fraction of CRC mortality in both countries, and more deaths could be avoided by increasing colonoscopy use in the target population. Attributable and prevented fraction can provide valuable information on the public health impact of colonoscopy use and guide policymaking.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Chen C, Stock C, Hoffmeister M, et al. Public health impact of colonoscopy use on colorectal cancer mortality in Germany and the United States. Gastrointest Endosc. 2017. PMID: 28431951. doi:10.1016/j.gie.2017.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。